Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgaf031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Mei Dong und 39 weiteren Autor:innen. Beteiligte Einrichtung: Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Genome-Wide Association Study, Lung Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, NCI NIH HHS.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer mortality. To investigate genetic determinants for prognosis among patients diagnosed with early-stage non-small cell lung cancer (NSCLC), we conducted the first large-scale genome-wide association prognostic study using data from the International Lung Cancer Consortium (ILCCO) through a two-phase analysis. Phase 1 includes the discovery of genome-wide association studies analysis using a multivariable Cox PH model on 3428 NSCLC patients of European ancestry from 10 ILCCO participating studies to identify genetic variants associated with overall survival and validation analysis for genome-wide significant variants (P-value ≤5 × 10−8) using the Cancer Genome Atlas (TCGA). Phase 2 aims to identify causal variants using functional analyses of genome-wide significant and suggestive variants (P-value ≤1 × 10−5), including variant-epigenetic functional annotation (FAVOR), CHIP-seq data, variant-gene expression association, and colocalization analysis. We identified two significant variants; of those, a locus at 9q21.31 (rs117979484) was significant at the genome-wide level (P = 3.67 × 10−8) and validated in TCGA (P = 0.03). Three suggestive variants were found to have a putative epigenetic function: intronic variants rs149281784 (BCL7B gene) and rs148031766 (POM121 gene) both located at 7q11.23 and in moderate linkage disequilibrium with each other; and variant rs2471630 (SRCIN1 gene; 17q12). Specifically, variants rs149281784 and rs148031766 have potential regulatory roles in the transcriptional activation of the BCL7B gene and POM121 gene. Exploratory survival analyses in the squamous cell carcinomas subgroup also identified a significant variant, rs138467404 (GRHL-2 gene; 8q22.3) at a genome-wide level (P = 4.75 × 10−8) and validated by TCGA (P = 0.02). These new findings indicate potential novel pathways associated with early-stage NSCLC prognosis. Future research may validate additional genome-wide suggestive variants as being relevant for lung cancer outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.
- Department of Medical Genetics and Genomics, University of California, San Francisco, SF 94158, California.
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom.
- Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, QC G1V 4G5, Quebec, Canada.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
- Department of Neurosurgery, Duke University School of Medicine, Durham, NC 27710, United States.
ORCID-Profile: Mei Dong, Yohan Bosse, Philip Haycock, Don D Sin, David Zaridze, Matthew B Schabath, Sanjay S Shete, Xihong Lin, Geoffrey Liu, Wei Xu
Förderung
- World Health Organization
- NCI NIH HHS
Zitieren
APA
Dong, M., Thakral, A., Byrne, K. S., Bosse, Y., Zhou, H., Zhang, Y., Atkins, J., Haycock, P., Brown, M. C., Murison, K., Timens, W., Sin, D. D., Kothari, J., Gabriel, A. A. G., Zaridze, D., Savic, M., Lissowska, J., Świątkowska, B., Janout, V., …, & Xu, W. (2025). Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf031
Vancouver
Dong M, Thakral A, Byrne KS, Bosse Y, Zhou H, Zhang Y, et al. Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf031
BibTeX
@article{Dong2025,
author = {Dong, Mei and Thakral, Abhinav and Byrne, Karl Smith- and Bosse, Yohan and Zhou, Hufeng and Zhang, Yi and Atkins, Joshua and Haycock, Philip and Brown, M Catherine and Murison, Kiera and Timens, Wim and Sin, Don D and Kothari, Jui and Gabriel, Aurélie A G and Zaridze, David and Savic, Milan and Lissowska, Jolanta and Świątkowska, Beata and Janout, Vladimir and Holcatova, Ivana and Mukeria, Anush and Fernandez-Tardon, Guillermo and Davies, Michael P A and Triplette, Matthew and Schabath, Matthew B and Andrew, Angeline S and Chen, Chu and Taylor, Fiona and Field, John K and Tardon, Adonina and Shete, Sanjay S and Brennan, Paul and Landi, Maria Teresa and McKay, James and Amos, Christopher I and Lin, Xihong and Christiani, David C and Hung, Rayjean J and Liu, Geoffrey and Xu, Wei},
title = {Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgaf031}
}
EUVIMED